Consommation de drogues par voie itraveineuse et maladies rénales [Intravenous drug use and kidney disease]

Fiche du document

Date

1 mars 2023

Types de document
Périmètre
Langue
Identifiants
Relations

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2023.19.816.411

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/36876391

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_D7282904BCED1

Licences

info:eu-repo/semantics/embargoedAccess , Restricted: cannot be viewed until 2024-09-01 , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/




Citer ce document

S. Rosset-Zufferey et al., « Consommation de drogues par voie itraveineuse et maladies rénales [Intravenous drug use and kidney disease] », Serveur académique Lausannois, ID : 10.53738/REVMED.2023.19.816.411


Métriques


Partage / Export

Résumé 0

Intravenous drug use (IVDU) is a major public health issue, associated with high mortality rates. The risk of overdose, cardiovascular and infectious complications are well known, but IVDU can also lead to different types of kidney disease. Patients can develop acute or chronic kidney injury due to direct nephrotoxicity of the drugs, or present with different types of glomerulonephritis, interstitial nephritis, and bacterial or viral infection-related nephropathy. Diagnosis can be difficult but is essential to prevent irreversible kidney damage. The number of persons with IVDU that develop end-stage kidney disease is increasing and poses challenges for dialysis and transplantation centers. This article summarizes the renal manifestations that clinicians may encounter in persons with IVDU, especially of heroin and cocaine.

document thumbnail

Par les mêmes auteurs

Sur les mêmes sujets

Exporter en